• Article

Acute Pain: A Multifaceted Challenge - The Role of Nimesulide

BACKGROUND: This article summarizes the outcome from an international consensus meeting, which took place in Vienna on November 4th, 2014. SCOPE: The aim of the meeting was to provide the state of the art on the pathophysiology and treatment of acute pain with special emphasis on nimesulide, a non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of acute pain and primary dysmenorrhea. Besides the data on the mechanisms of acute inflammatory pain and on the efficacy and safety of nimesulide in patients affected by different forms of acute pain, the clinical experience of attending experts was discussed based on selected case reports. RESULTS: The members of this consensus group recognised that nimesulide is a NSAID highly effective in the treatment of several painful situations with an acute inflammatory component including primary dysmenorrhoea. Although safety concerns regarding nimesulide have emerged in recent years, both robust new epidemiological data and clinical experience confirm a positive benefit/risk profile of nimesulide in the treatment of several forms of acute pain. CONCLUSIONS: The members of this international consensus group concluded that nimesulide, when used appropriately, remains a particularly valuable and safe option for the treatment of several conditions characterised by the presence of acute inflammatory pain because of the rapid onset of the analgesic action, and the positive evidence-based benefit/risk profile


Kress, H., Baltov, A., Basinski, A., Berghea, F., Castellsague, J., Codreanu, C., ... Woron, J. (2016). Acute Pain: A Multifaceted Challenge - The Role of Nimesulide. Current Medical Research and Opinion, 32(1), 23-36. https://doi.org/10.1185/03007995.2015.1100986